MSD Fined €39m In Spain Over Blocking Nuvaring Rival

Insud Pharma’s Ornibel Version Suffered Following Originator Abuse Of Dominant Position

 
• By David Wallace
  
CNMC Spain Logo Phone
The CNMC has fined MSD €39m for abuse of dominant position • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Legal & IP

More from Generics Bulletin